{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:22:33Z","timestamp":1777026153422,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1002\/jps.22524","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T17:32:11Z","timestamp":1298482331000},"page":"2952-2965","source":"Crossref","is-referenced-by-count":20,"title":["Single-Step Preparation and Deagglomeration of Itraconazole Microflakes by Supercritical Antisolvent Method for Dissolution Enhancement"],"prefix":"10.1016","volume":"100","author":[{"given":"Sateesh Kumar","family":"Sathigari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney A.","family":"Ober","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh P.","family":"Sanganwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram B.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jayachandra","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1002\/jps.22524_bb0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"issue":"11","key":"10.1002\/jps.22524_bb0010","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1023\/B:PHAM.0000048196.61887.e5","article-title":"Development and Characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs","volume":"21","author":"Rogers","year":"2004","journal-title":"Pharm Res"},{"issue":"12","key":"10.1002\/jps.22524_bb0015","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1023\/A:1021410028371","article-title":"Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs","volume":"19","author":"Rasenack","year":"2002","journal-title":"Pharm Res"},{"issue":"5","key":"10.1002\/jps.22524_bb0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00562664","article-title":"Effect of particle size on the bioavailability of digoxin","volume":"8","author":"Jounela","year":"1975","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1002\/jps.22524_bb0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0378-5173(95)00122-Y","article-title":"Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs","volume":"125","author":"Liversidge","year":"1995","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1002\/jps.22524_bb0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejpb.2007.05.010","article-title":"Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: Comparison with commercial preparations","volume":"68","author":"Vogt","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"issue":"2\u20133","key":"10.1002\/jps.22524_bb0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0378-5173(92)90121-H","article-title":"Effect of various cyclodextrins on solution stability and dissolution rate of doxorubicin hydrochloride","volume":"79","author":"Brewster","year":"1992","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1002\/jps.22524_bb0040","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ejpb.2008.06.024","article-title":"Inclusion complexes of tadalafil with natural and chemically modified beta -cyclodextrins. I: Preparation and in-vitro evaluation","volume":"70","author":"Badr-Eldin","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1002\/jps.22524_bb0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1208\/s12249-008-9180-3","article-title":"Physicochemical characterization of efavirenz\u2013cyclodextrin inclusion complexes","volume":"10","author":"Sathigari","year":"2009","journal-title":"AAPS Pharm Sci Tech"},{"issue":"9","key":"10.1002\/jps.22524_bb0050","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/03639040902783074","article-title":"Gefitinib\u2013cyclodextrin inclusion complexes: Physico-chemical characterization and dissolution studies","volume":"35","author":"Phillip Lee","year":"2009","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1002\/jps.22524_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpharm.2003.09.002","article-title":"Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol\u2013polysorbate 80 mixture","volume":"269","author":"Joshi","year":"2004","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1002\/jps.22524_bb0060","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jps.20044","article-title":"Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol\u2013polysorbate 80 solid dispersion carrier system","volume":"93","author":"Dannenfelser","year":"2004","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1002\/jps.22524_bb0065","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1021\/mp800061r","article-title":"Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: A case study","volume":"5","author":"Kennedy","year":"2008","journal-title":"Mol Pharm"},{"issue":"1\u20132","key":"10.1002\/jps.22524_bb0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpharm.2005.10.026","article-title":"Use of compressed gas precipitation to enhance the dissolution behavior of a poorly water-soluble drug: Generation of drug microparticles and drug-polymer solid dispersions","volume":"308","author":"Muhrer","year":"2006","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1002\/jps.22524_bb0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejpb.2006.07.003","article-title":"Improved absorption of meloxicam via salt formation with ethanolamines","volume":"65","author":"Han","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20132","key":"10.1002\/jps.22524_bb0080","first-page":"156","article-title":"Enhanced bioavailability of piroxicam via salt formation with ethanolamines","volume":"297","author":"Gwak","year":"2005","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1002\/jps.22524_bb0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0378-5173(01)00717-7","article-title":"Comparison of the physicochemical properties of the N-(2-hydroxyethyl)pyrrolidine, diethylamine and sodium salt forms of diclofenac","volume":"222","author":"O'Connor","year":"2001","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1002\/jps.22524_bb0090","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/jps.20118","article-title":"Surfactant-mediated dissolution: Contributions of solubility enhancement and relatively low micelle diffusivity","volume":"93","author":"Balakrishnan","year":"2004","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1002\/jps.22524_bb0095","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11095-006-9203-2","article-title":"Surfactant-polymer nanoparticles: A novel platform for sustained and enhanced cellular delivery of water-soluble molecules","volume":"24","author":"Chavanpatil","year":"2007","journal-title":"Pharm Res"},{"issue":"11","key":"10.1002\/jps.22524_bb0100","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/jps.2600651137","article-title":"Enhancement of dissolution rates of poorly water-soluble drugs by crystallization in aqueous surfactant solutions. I: Sulfathiazole, prednisone, and chloramphenicol","volume":"65","author":"Chiou","year":"1976","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1002\/jps.22524_bb0105","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/03639040500272108","article-title":"Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutions","volume":"31","author":"Granero","year":"2005","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1002\/jps.22524_bb0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2006.03.001","article-title":"Enhancement of the dissolution rate and oral absorption of a poorly water-soluble drug by formation of surfactant-containing microparticles","volume":"317","author":"Wong","year":"2006","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1002\/jps.22524_bb0115","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/jps.20067","article-title":"Solubilization behavior of poorly soluble drugs with combined use of Gelucire 44\/14 and cosolvent","volume":"93","author":"Kawakami","year":"2004","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"10.1002\/jps.22524_bb0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-5173(03)00065-6","article-title":"Solubility enhancement of low soluble biologically active compounds\u2014temperature and cosolvent dependent inclusion complexation","volume":"256","author":"Viernstein","year":"2003","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1002\/jps.22524_bb0125","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.addr.2007.05.011","article-title":"Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates","volume":"59","author":"Blagden","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1002\/jps.22524_bb0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0896-8446(01)00064-X","article-title":"Particle design using supercritical fluids: Literature and patent survey","volume":"20","author":"Jung","year":"2001","journal-title":"J Supercrit Fluids"},{"issue":"2\u20133","key":"10.1002\/jps.22524_bb0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0378-5173(86)90188-2","article-title":"Properties and dissolution of drugs micronized by crystallization from supercritical gases","volume":"32","author":"Loth","year":"1986","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1002\/jps.22524_bb0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1208\/ps050211","article-title":"Application of dense gas techniques for the production of fine particles","volume":"5","author":"Foster","year":"2003","journal-title":"PharmSci"},{"issue":"10","key":"10.1002\/jps.22524_bb0145","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/jps.10471","article-title":"Drug nano and microparticles processed into solid dosage forms: Physical properties","volume":"92","author":"Jonghwi","year":"2003","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1002\/jps.22524_bb0150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1081\/DDC-100101270","article-title":"Improved bioavailability of a micronized megestrol acetate tablet formulation in humans","volume":"26","author":"Farinha","year":"2000","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"10.1002\/jps.22524_bb0155","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0010-7824(87)90088-6","article-title":"Oral micronized progesterone. Bioavailability pharmacokinetics, pharmacological and therapeutic implications\u2014A review","volume":"36","author":"Sitruk-Ware","year":"1987","journal-title":"Contraception"},{"issue":"6","key":"10.1002\/jps.22524_bb0160","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s11095-007-9479-x","article-title":"Increasing the dissolution rate of itraconazole processed by gas antisolvent techniques using polyethylene glycol as a carrier","volume":"25","author":"Barrett","year":"2008","journal-title":"Pharm Res"},{"issue":"8","key":"10.1002\/jps.22524_bb0165","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1351\/pac200173081293","article-title":"Supercritical fluids-assisted micronization techniques. Low-impact routes for particle production","volume":"73","author":"Reverchon","year":"2001","journal-title":"Pure Appl Chem"},{"issue":"3","key":"10.1002\/jps.22524_bb0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.addr.2007.08.030","article-title":"Supercritical fluid technologies: An innovative approach for manipulating the solid-state of pharmaceuticals","volume":"60","author":"Pasquali","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10.1002\/jps.22524_bb0175","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1021\/jp9931511","article-title":"Mechanism governing microparticle morphology during precipitation by a compressed antisolvent: Atomization vs nucleation and growth","volume":"104","author":"Lengsfeld","year":"2000","journal-title":"J Phys Chem B"},{"issue":"2","key":"10.1002\/jps.22524_bb0180","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cej.2009.10.052","article-title":"Interactions of phase equilibria, jet fluid dynamics and mass transfer during supercritical antisolvent micronization","volume":"156","author":"Reverchon","year":"2010","journal-title":"Chem Eng J"},{"issue":"2","key":"10.1002\/jps.22524_bb0185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.supflu.2004.12.012","article-title":"Operating regimes and mechanism of particle formation during the precipitation of polymers using the PCA process","volume":"35","author":"Perez de Diego","year":"2005","journal-title":"J Supercrit Fluids"},{"issue":"2","key":"10.1002\/jps.22524_bb0190","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/10837450600691237","article-title":"Identification of critical process variables affecting particle size following precipitation using a supercritical fluid","volume":"11","author":"Sacha","year":"2006","journal-title":"Pharm Dev Technol"},{"issue":"2","key":"10.1002\/jps.22524_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/10837450600561299","article-title":"Identification of physical-chemical variables affecting particle size following precipitation using a supercritical fluid","volume":"11","author":"Sacha","year":"2006","journal-title":"Pharm Dev Technol"},{"issue":"1","key":"10.1002\/jps.22524_bb0200","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.supflu.2007.04.013","article-title":"Nanoparticles production by supercritical antisolvent precipitation: A general interpretation","volume":"43","author":"Reverchon","year":"2007","journal-title":"J Supercrit Fluids"},{"issue":"10","key":"10.1002\/jps.22524_bb0205","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/jps.2600561006","article-title":"Deaggregation behavior of a relatively insoluble substituted benzoic acid and its sodium salt","volume":"56","author":"Aguiar","year":"1967","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1002\/jps.22524_bb0210","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1081\/DDC-100100270","article-title":"Dissolution properties of piroxicam powders and capsules as a function of particle size and the agglomeration of powders","volume":"26","author":"Swanepoel","year":"2000","journal-title":"Drug Dev Ind Pharm"},{"issue":"1,2","key":"10.1002\/jps.22524_bb0215","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0378-5173(95)04380-2","article-title":"Influence of agglomeration of cohesive particles on the dissolution behavior of furosemide powder","volume":"136","author":"de Villiers","year":"1996","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1002\/jps.22524_bb0220","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejpb.2008.12.015","article-title":"Drug agglomeration and dissolution\u2013What is the influence of powder mixing?","volume":"72","author":"Kale","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"10.1002\/jps.22524_bb0225","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1461-5347(00)00283-2","article-title":"An engineering view of pharmaceutical powder mixing","volume":"3","author":"Harnby","year":"2000","journal-title":"Pharm Sci Technol Today"},{"issue":"1\u20133","key":"10.1002\/jps.22524_bb0230","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejps.2009.11.011","article-title":"Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement","volume":"39","author":"Sanganwar","year":"2010","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1002\/jps.22524_bb0235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpba.2007.06.011","article-title":"Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide","volume":"45","author":"Hassan","year":"2007","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"10.1002\/jps.22524_bb0240","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3797\/scipharm.0901-08","article-title":"Synergistic enhancement of itraconazole dissolution by ternary system formation with pluronic F68 and hydroxypropylmethylcellulose","volume":"77","author":"El Maghraby","year":"2009","journal-title":"Sci Pharm"},{"issue":"3\u20134","key":"10.1002\/jps.22524_bb0245","first-page":"213","article-title":"Increasing solubility and dissolution rate of drugs via eutectic mixtures: Itraconazole-poloxamer 188 system","volume":"1","author":"Liu","year":"2006","journal-title":"Asian J Pharm Sci (Hong Kong, China)"},{"issue":"1","key":"10.1002\/jps.22524_bb0250","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejpb.2007.11.006","article-title":"Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica","volume":"69","author":"Mellaerts","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.22524_bb0255","doi-asserted-by":"crossref","unstructured":"Mellaerts R, Aerts A, Caremans TP, Vermant J, Van Den Mooter G, Martens JA, Augustijns P. Growth of itraconazole nanofibers in supersaturated simulated intestinal fluid. Mol Pharm 7(3):905\u2013913.","DOI":"10.1021\/mp900300j"},{"issue":"1\u20132","key":"10.1002\/jps.22524_bb0260","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijpharm.2009.05.060","article-title":"Levitated single-droplet drying: Case study with itraconazole dried in binary organic solvent mixtures","volume":"378","author":"Wulsten","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22524_bb0265","first-page":"117","article-title":"Phase-solubility techniques","volume":"4","author":"Higuchi","year":"1965","journal-title":"Adv Anal Chem Instr"},{"issue":"2","key":"10.1002\/jps.22524_bb0270","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11095-006-9146-7","article-title":"Particle size analysis in pharmaceutics: Principles, methods and applications","volume":"24","author":"Shekunov","year":"2007","journal-title":"Pharm Res"},{"issue":"2","key":"10.1002\/jps.22524_bb0275","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.powtec.2007.02.029","article-title":"Micronization of cilostazol using supercritical antisolvent (SAS) process: Effect of process parameters","volume":"177","author":"Kim","year":"2007","journal-title":"Powder Technol"},{"issue":"2","key":"10.1002\/jps.22524_bb0280","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/aic.690480207","article-title":"Protein nanoparticles formation by supercritical antisolvent with enhanced mass transfer","volume":"48","author":"Chattopadhyay","year":"2002","journal-title":"AIChE J"},{"issue":"14","key":"10.1002\/jps.22524_bb0285","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1021\/ie8000343","article-title":"Enhancement of shelf life and handling properties of drug nanoparticles: Nanoscale mixing of itraconazole with silica","volume":"47","author":"Sanganwar","year":"2008","journal-title":"Ind Eng Chem Res"},{"issue":"1\u20132","key":"10.1002\/jps.22524_bb0290","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2005.06.027","article-title":"Stabilizer choice for rapid dissolving high potency itraconazole particles formed by evaporative precipitation into aqueous solution","volume":"302","author":"Sinswat","year":"2005","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1002\/jps.22524_bb0295","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/ja02086a003","article-title":"The rate of solution of solid substances in their own solutions","volume":"19","author":"Noyes","year":"1897","journal-title":"J Am Chem Soc"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915320852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915320852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T19:53:59Z","timestamp":1560023639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915320852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022354915320852"],"URL":"https:\/\/doi.org\/10.1002\/jps.22524","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}